Gastrointestinal
Cancer Center of Excellence at Saint Barnabas
About Our Center
The Cancer Surgery Service of Saint Barnabas
offers expert, state-of-the-art surgery for the simplest to the
most complex oncology problems. Designed specifically to meld into
a multidisciplinary care plan combining surgery with radiation therapy
and chemotherapy as necessary, our expert surgical oncologists emphasize
patient-centered, compassionate, and holistic care.
Uniquely, the Gastrointestinal Cancer Center
of Excellence possesses surgical expertise in the management of
upper gastrointestinal tract tumors (esophagus, stomach, duodenum,
pancreas, bile duct and liver), soft tissue sarcomas, melanoma,
and endocrine tumors. Our surgeons are among the most accomplished
and highly trained in the region and make every effort to apply
minimally invasive/laparoscopic techniques whenever feasible. Specific
therapies offered include
- Selective Internal Radiation Therapy (SIRT) for inoperable liver cancer
- Complex liver, pancreatic and biliary surgery
for both malignant and benign disease
- Biliary reconstruction for malignancy, benign
stricture, or following bile duct injury
- Laparoscopic liver, pancreatic and adrenal
surgery
- Radiofrequency ablation of liver tumors
- Insertion of hepatic arterial pump surgery.
- Heated intraperitoneal
chemotherapy for advanced tumors confined to the peritoneal cavity
- Yttrium microsphere therapy for unresctable
colorectal metastases
About
Our Physicians
Ronald
Chamberlain, MD, MPA, FACS
Chairman of the Department of Surgery
Dr. Chamberlain specializes in surgical oncology
(cancer surgery) with a particular emphasis in upper gastrointestinal
surgery (stomach, bile duct, gall bladder, duodenum, and liver and
pancreas), sarcoma surgery, and advanced laparoscopic surgery. In
addition to performing surgery, Dr. Chamberlain serves as Surgical
Director of Cancer Surgery Services at SBMC, surgical leader of
the Cancer Committee, and chair of the Operating Room Committee.
He has developed a multidisciplinary Gastrointestinal Cancer Center
of Excellence at Saint Barnabas to meet the complex needs of these
patients.
Prior to joining the Saint Barnabas staff in
2004, Dr. Chamberlain served as Chief of Hepatobiliary and Pancreatic
Surgery, Program Director of the General Surgery Residency and Assistant
Professor of Surgery at Beth Israel Medical Center Albert Einstein
College of Medicine in New York. He has completed a Surgical Oncology
Fellowship at the National Cancer Institute, a Hepatobiliary Surgery
Fellowship at Memorial Sloan-Kettering Cancer Center and a Minimally
Invasive Surgery Mini-Fellowship at Yale University School of Medicine.
Dr. Chamberlain was named to the New Jersey, New York Metro Area,
and New York Magazine Best Doctor’s list.
In addition, he has published more than 75 peer
reviewed publications, and has written or edited more than nine
text books, including Hepatobiliary Surgery (with Dr. Leslie Blumgart)
and The Surgical Intern Survival Guide that is used by interns and
residents nationwide and is in its eleventh printing.
Vivek
Maheshswari, MD
Co-Director, Gastrointestinal Cancer Center of Excellence at Saint
Barnabas
As a surgical oncologist Dr. Maheshswari specializes
in gastrointestinal cancers and offers unique expertise and research
interest in heated peritoneal perfusion through his experiences
at the University of Pittsburgh Cancer Center. He is board certified
in General Surgery and will provide state-of-the-art surgical services
to patients with GI cancers, endocrine tumors and melanomas.
Prior to joining Saint Barnabas in 2006, Dr.
Maheshwari was a full-time surgical oncology faculty member at Beth
Israel Medical Center in New York and Assistant Professor at the
Albert Einstein College of Medicine. He is a Fellow of the American
College of Surgeons as well as a member of the Society of Surgical
Oncology, American Society of Clinical Oncology and Society of Surgery
for the Alimentary Tract where he is involved with a variety of
local and national cooperative trials.
Dr. Maheshwari received his medical and Master
of Surgery degrees from the University of Delhi in India and completed
his general surgery residency at Beth Israel Medical Center. He
went on to complete his Society of Surgical Oncology Fellowship
at the University of Pittsburgh. He is actively involved in a variety
of clinical research projects and has special interests in cutaneous
oncology, endocrine tumors, tumor debulking and intraperitoneal
hyperthermic chemotherapy.
Heated Intraperitoneal
Chemotherapy
Heated Chemotherapy Offers Advance Abdominal
Cancer Patients Longer Life
Until recently, treatment options for patients
with advanced abdominal cancers could only provide relief from symptoms,
with no hope of stopping the disease from recurring or prolonging
life.
Now, with the use of heated intraperitoneal
chemotherapy using the FDA-approved ThermoChem(TM) HT-1000 System,
surgeons at Saint Barnabas have the potential to dramatically improve
the outlook for late-stage patients with colon/rectal cancer, ovarian/uterine
cancer, cancer of the small bowel, and pseudomyxoma peritonei syndrome,
a rare malignant disorder.
The potent combination of heat, chemotherapy
and specialized surgery offers an extended outlook for patients
with otherwise untreatable abdominal cancers, most of whom have
been given three to six months to live. The specialized system reports
response rates of up to 25 percent of patients achieving a greater
than two year survival rate.
This new technology allows surgeons to direct
a heated sterile solution throughout the entire abdomen, a treatment
commonly referred to as Intraperitoneal Hyperthermia (IPH) or Heated
Chemotherapy.
What is Heated Chemotherapy?
ThermoChem(TM) is the first and only FDA approved
device for IPH. Surgeons use IPH in conjunction with a lengthy 8-10
hour surgery, removing as many tumors as possible from the abdominal
cavity. Then, two small incisions are made and tubes are inserted,
one to pump the heated chemotherapy into the patient and the other
to circulate it back into the machine. The chemotherapy circulates
for approximately two hours.
How Does Heated Chemotherapy Work?
Heat kills cancer cells at temperatures where
normal cells remain unharmed. Heating the chemotherapeutic agents
makes them more effective at killing cancer cells than they would
be at normal temperatures. Circulating the heated chemotherapy throughout
the peritoneal and abdominal cavity allows the drugs to be distributed
thoroughly and penetrate directly, without subjecting you to the
side effects of these drugs if given intravenously.
Is Heated Chemo Right for You?
Because such surgery is a major procedure that
is not without risk and because the recovery can be substantial,
Heated Chemotherapy is not for everyone. To find out if you are
a candidate, please contact 973-322-5195 to make an appointment
with a surgeon at Saint Barnabas.
Contact Us
For more information about the Cancer Surgery
Services or the Gastrointestinal Cancer Center of Excellence at
Saint Barnabas, please call (973) 332-5195.
[ top ] |